Frazier Jones, MD
Orthopaedic Surgery of the Spine · Opelika, ALNPI 1962454520
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Amgen accounts for 70.0% of it on its own, with 2 other manufacturers making up the rest. That places this record below the midpoint for orthopaedic surgery of the spine clinicians in AL, where the typical reported total is $8,697.
Across 6 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$75
- Abbott$17
- Endo Pharmaceuticals Inc.$15
What the payments were for
- Food & beverage$108100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 4 | $75 |
| Abbott | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
How this compares
$108 in reported general payments places this provider in the 0th percentile of 20 orthopaedic surgery of the spine providers in Alabama.
See all orthopaedic surgery of the spine providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 359 | $7,338 |
| Meloxicam | 770 | $2,861 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 317 | $2,806 |
| Ibandronate Sodium | 47 | $1,761 |
| Diclofenac Sodium | 80 | $1,596 |
| Gabapentin | 194 | $1,318 |
| Tramadol Hcl | 263 | $850 |
| Methylprednisolone | 88 | $746 |
| Cyclobenzaprine Hcl | 104 | $393 |
| Doxycycline Hyclate | 12 | $369 |
| Methocarbamol | 23 | $357 |
| Etodolac | 11 | $284 |
| Ibuprofen | 20 | $197 |
| Clindamycin Hcl | 25 | $178 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $172 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Opelika
- Javier RetoHuntsville$768K
- Timothy HoltMontgomery$478K
- Timothy BassettTuscaloosa$291K
- Phillip KravetzCullman$224K
- Charles GordonDaphne$208K
- Larry ParkerHuntsville$136K
- Todd VolkmanMobile$34K
- Bendt PetersenMobile$30K
- James WestMobile$25K
- Asra ToobaieMobile$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.